AUG 20, 2017 7:53 PM PDT

Preventing Lethal Shock During Hemorrhagic Fevers

WRITTEN BY: Kara Marker

The body can go into “shock” for several different reasons, but it’s never a good sign. Whatever the source of shock, the condition is lethal if left untreated (and sometimes leads to death even with treatment). From the University of Basel, researchers are looking at a common cause of shock, hemorrhagic fevers from viral infections, to find new, more effective treatments.

A transmission electron micrograph (TEM) of a number of Lassa virus virions adjacent to some cell debris. Source: CDC's Public Health Image Library

Hemorrhagic fever describes what happens to the body when multiple body organs are damaged as the body’s vascular system is breaking down. When hemorrhagic fevers lead to shock, the body’s blood pressure is so low that there is not enough oxygen in the body to prevent organ failure. Someone in shock might feel cold, anxious, and confused, or look pale with dilated pupils. Treatment options often depend on what the source of shock is (it can be from an allergic reaction, infections in the blood, a heart deficiency, or even an emotional disturbance). Oxygen, IV fluids, blood transfusion, or blood vessel-constricting drugs to direct blood flow to the heart and brain are a few options.

Lassa virus is transmitted to humans by rodents, causing a hemorrhagic fever reminiscent of the Ebola virus. This type of infection is particularly common in West Africa, and at the very last stage of the disease, people go into shock, usually leading to death. In a new study published in the journal Cell Host & Microbe, researchers use Lassa virus as a way to study what happens in the body to trigger hemorrhagic fever, with the hope of using that information to someday develop new therapies.

Interestingly, researchers identified T cells at the root of circulatory failure. T cells are a key part of the adaptive immune system, the branch that designs a specific attack against pathogenic invaders, so implicating T cells in contributing to shock was surprising.

They found that T cells “convince” so-called “scavenger” cells to mass-produce nitric oxide (NO) by releasing a substance called interferon gamma. However, NO is an antibacterial chemical; it has no power over viral infections. Instead, NO triggers blood vessel dilation, the first step toward what will eventually be circulatory failure. However, researchers already see the benefits of blocking the production of interferon gamma to prevent circulatory failure.

With a key trigger of shock identified, researchers are already moving forward on applying this knowledge in the clinic to prevent shock-related death.

Sources: LiveScience, CDC, University of Basel

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 24, 2021
Immunology
Women Produce More COVID Antibodies Than Men
AUG 24, 2021
Women Produce More COVID Antibodies Than Men
An exploration into the human immune response after a COVID-19 infection has revealed a surprising finding: women produc ...
SEP 07, 2021
Health & Medicine
Think you can pay back your sleep debt this weekend? Think again.
SEP 07, 2021
Think you can pay back your sleep debt this weekend? Think again.
Researchers find that even one night of sleep loss results in impaired functioning and well being.
SEP 14, 2021
Immunology
The Spleen Creates Long-Lasting Protection Against the Flu Virus
SEP 14, 2021
The Spleen Creates Long-Lasting Protection Against the Flu Virus
You share an elevator with an individual who is coughing and sneezing, only to find yourself feeling unwell a few days l ...
SEP 13, 2021
Microbiology
Flu Season Looms Large as World May Have an 'Immunity Debt'
SEP 13, 2021
Flu Season Looms Large as World May Have an 'Immunity Debt'
Scientists are beginning to speculate about the possibility that the flu season this year will be particularly bad becau ...
OCT 12, 2021
Drug Discovery & Development
Preventing future pandemics - Scientists developing broadly protective vaccines against coronaviruses
OCT 12, 2021
Preventing future pandemics - Scientists developing broadly protective vaccines against coronaviruses
Researchers at Japan’s Osaka University recently developed and tested a novel vaccine that may protect a ...
NOV 05, 2021
Cancer
The Labroots 2021 Cancer Research and Oncology Virtual Event Poster Winner
NOV 05, 2021
The Labroots 2021 Cancer Research and Oncology Virtual Event Poster Winner
Every year, Labroots hosts an exciting series of Virtual Events that focus on various scientific topics. These virtual m ...
Loading Comments...